Antifungal agents: chemotherapeutic targets and immunologic strategies.
作者信息
Georgopapadakou N H, Walsh T J
机构信息
Department of Oncology, Roche Research Center, Nutley, New Jersey 07110, USA.
出版信息
Antimicrob Agents Chemother. 1996 Feb;40(2):279-91. doi: 10.1128/AAC.40.2.279.
Abstract
摘要
相似文献
1
Antifungal agents: chemotherapeutic targets and immunologic strategies.抗真菌药物：化疗靶点与免疫策略。
Antimicrob Agents Chemother. 1996 Feb;40(2):279-91. doi: 10.1128/AAC.40.2.279.
2
Human mycoses: drugs and targets for emerging pathogens.人类真菌病：新兴病原体的药物与靶点
Science. 1994 Apr 15;264(5157):371-3. doi: 10.1126/science.8153622.
3
Immunomodulatory properties of antifungal agents on phagocytic cells.抗真菌药物对吞噬细胞的免疫调节特性。
Immunol Invest. 2011;40(7-8):809-24. doi: 10.3109/08820139.2011.615877.
4
Antifungal drugs and resistance.抗真菌药物与耐药性
Adv Exp Med Biol. 1995;390:217-34. doi: 10.1007/978-1-4757-9203-4_19.
5
New drugs target growing threat of fatal fungi.
Science. 2019 Oct 25;366(6464):407. doi: 10.1126/science.366.6464.407.
6
Further studies on antimycotic agents.
Mykosen. 1986 Sep;29(9):407-12.
7
Potential targets for the development of new antifungal drugs.新型抗真菌药物的潜在靶点。
J Antibiot (Tokyo). 2018 Nov;71(12):978-991. doi: 10.1038/s41429-018-0100-9. Epub 2018 Sep 21.
8
Strategies in the discovery of novel antifungal scaffolds.新型抗真菌骨架的发现策略。
Future Med Chem. 2016 Aug;8(12):1435-54. doi: 10.4155/fmc-2016-0020. Epub 2016 Jul 27.
9
[Antifungal resistance in opportunistic pathogenic fungi (I). Polyenes and fluorocytosine].[机会性致病真菌中的抗真菌耐药性（I）。多烯类和氟胞嘧啶]
Enferm Infecc Microbiol Clin. 1996 Jun-Jul;14(6):384-9.
10
Antifungal antibiotics.抗真菌抗生素
Appl Microbiol Biotechnol. 2002 Jan;58(1):46-57. doi: 10.1007/s002530100822.
引用本文的文献
1
Effects of Nisin A Combined with Antifungal Drug Against Growth of Species.乳酸链球菌素A与抗真菌药物联合使用对菌种生长的影响。
Dent J (Basel). 2025 Apr 8;13(4):160. doi: 10.3390/dj13040160.
2
Aspergillus fumigatus mitogenomes and their influence on azole-resistant and -susceptible populations.烟曲霉线粒体基因组及其对唑类耐药和敏感群体的影响。
NPJ Antimicrob Resist. 2025 Feb 27;3(1):15. doi: 10.1038/s44259-025-00083-6.
3
The Kelch Repeat Protein VdKeR1 Is Essential for Development, Ergosterol Metabolism, and Virulence in .kelch重复蛋白VdKeR1对……的发育、麦角固醇代谢和毒力至关重要。 （原文中“in”后面缺少具体内容）
J Fungi (Basel). 2024 Sep 9;10(9):643. doi: 10.3390/jof10090643.
4
Primary cilia-associated signalling in squamous cell carcinoma of head and neck region.头颈部鳞状细胞癌中初级纤毛相关信号传导
Front Oncol. 2024 Aug 21;14:1413255. doi: 10.3389/fonc.2024.1413255. eCollection 2024.
5
Azole resistance mechanisms and population structure of the human pathogen on retail plant products.唑类耐药机制与人类病原体在零售植物产品中的种群结构。
Appl Environ Microbiol. 2024 May 21;90(5):e0205623. doi: 10.1128/aem.02056-23. Epub 2024 Apr 23.
6
Direct synthesis of branched amines enabled by dual-catalyzed allylic C─H amination of alkenes with amines.通过烯烃与胺的双催化烯丙基C─H胺化实现支链胺的直接合成。
Sci Adv. 2024 Apr 5;10(14):eadn1272. doi: 10.1126/sciadv.adn1272.
7
Therapeutic Updates on the Management of Tinea Corporis or Cruris in the Era of : Separating Evidence from Hype-A Narrative Review.时代背景下体癣或股癣治疗的最新进展：区分证据与炒作——一篇叙述性综述
Indian J Dermatol. 2023 Sep-Oct;68(5):525-540. doi: 10.4103/ijd.ijd_832_23.
8
Superficial Dermatophytosis across the World's Populations: Potential Benefits from Nanocarrier-Based Therapies and Rising Challenges.全球人群中的浅表皮肤癣菌病：基于纳米载体疗法的潜在益处及日益增加的挑战
ACS Omega. 2023 Aug 22;8(35):31575-31599. doi: 10.1021/acsomega.3c01988. eCollection 2023 Sep 5.
9
Triazole fungicides induce adipogenesis and repress osteoblastogenesis in zebrafish.三唑类杀菌剂在斑马鱼中诱导脂肪生成并抑制成骨细胞生成。
Toxicol Sci. 2023 May 31;193(2):119-130. doi: 10.1093/toxsci/kfad031.
10
Developing novel antifungals: lessons from G protein-coupled receptors.开发新型抗真菌药物：G 蛋白偶联受体的启示。
Trends Pharmacol Sci. 2023 Mar;44(3):162-174. doi: 10.1016/j.tips.2022.12.002.
本文引用的文献
1
Is there a role for GPIs in yeast cell-wall assembly?葡糖基磷脂酰肌醇在酵母细胞壁组装中起作用吗？
Trends Cell Biol. 1994 Feb;4(2):42-5. doi: 10.1016/0962-8924(94)90003-5.
2
3
Hematopoietic reconstruction: new approaches.
Clin Cancer Res. 1995 Jan;1(1):3-9.
4
Resistance of yeasts to azole-derivative antifungals.酵母对唑类衍生物抗真菌药物的耐药性。
J Antimicrob Chemother. 1993 Apr;31(4):463-71. doi: 10.1093/jac/31.4.463.
5
Two mechanisms of butenafine action in Candida albicans.布替萘芬作用于白色念珠菌的两种机制。
Antimicrob Agents Chemother. 1993 Apr;37(4):785-8. doi: 10.1128/AAC.37.4.785.
6
Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.1980 - 1990年美国医院获得性真菌感染流行病学的长期趋势。国家医院感染监测系统。
J Infect Dis. 1993 May;167(5):1247-51. doi: 10.1093/infdis/167.5.1247.
7
8
Correlation of cilofungin in vivo efficacy with its activity against Aspergillus fumigatus (1,3)-beta-D-glucan synthase.西洛芬净体内疗效与其对烟曲霉（1,3）-β-D-葡聚糖合酶活性的相关性。
FEMS Microbiol Lett. 1993 Apr 1;108(2):133-7. doi: 10.1111/j.1574-6968.1993.tb06088.x.
9
Studies on the mode of antifungal action of pradimicin antibiotics. II. D-mannopyranoside-binding site and calcium-binding site.普拉地米星抗生素抗真菌作用模式的研究。II. D-甘露吡喃糖苷结合位点和钙结合位点。
J Antibiot (Tokyo). 1993 Mar;46(3):455-64. doi: 10.7164/antibiotics.46.455.
10
Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection.抗体介导的对致死性脑内新型隐球菌感染小鼠的保护作用。
Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3636-40. doi: 10.1073/pnas.90.8.3636.
Zotero 插件